Authors:
Monetini, L
Cavallo, MG
Stefanini, L
Ferrazzoli, F
Bizzarri, C
Marietti, G
Curro, V
Cervoni, M
Pozzilli, P
Citation: L. Monetini et al., Bovine beta-casein antibodies in breast- and bottle-fed infants: their relevance in Type 1 diabetes, DIABET M R, 17(1), 2001, pp. 51-54
Authors:
Crino, A
Cavallo, MG
Corbi, S
Mesturino, CA
Ferrazzoli, F
Coppolino, G
Bizzarri, C
Cervoni, M
Monetini, L
Pozzilli, P
Citation: A. Crino et al., Intradermal skin test with diabetes specific antigens in patients with type 1 diabetes, CLIN EXP IM, 123(3), 2001, pp. 382-386
Authors:
Tiberti, C
Buzzetti, R
Anastasi, E
Dotta, F
Vasta, M
Petrone, A
Cervoni, M
Torresi, P
Vecci, E
Multari, G
Di Mario, U
Citation: C. Tiberti et al., Autoantibody negative new onset type 1 diabetic patients lacking high riskHLA alleles in a Caucasian population: are these Type 1b diabetes cases?, DIABET M R, 16(1), 2000, pp. 8-14
Authors:
Pozzilli, P
Pitocco, D
Visalli, N
Cavallo, MG
Buzzetti, R
Crino, A
Spera, S
Suraci, C
Multari, G
Cervoni, M
Bitti, MLM
Matteoli, MC
Marietti, G
Ferrazzoli, F
Faldetta, MRC
Giordano, C
Sbriglia, M
Sarugeri, E
Ghirlanda, G
Citation: P. Pozzilli et al., No effect of oral insulin on residual beta-cell function in resent-onset Type I diabetes (the IMDIAB VII), DIABETOLOG, 43(8), 2000, pp. 1000-1004
Authors:
Visalli, N
Cavallo, MG
Signore, A
Baroni, MG
Buzzetti, R
Fioriti, E
Mesturino, C
Fiori, R
Lucentini, L
Matteoli, MC
Crino, A
Corbi, S
Spera, S
Teodonio, C
Paci, F
Amoretti, R
Pisano, L
Suraci, C
Multari, G
Sulli, N
Cervoni, M
De Mattia, G
Faldetta, MRC
Boscherini, B
Bitti, MLM
Marietti, G
Ferrazzoli, F
Bizzarri, C
Pitocco, D
Ghirlanda, G
Pozzilli, P
Citation: N. Visalli et al., A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI), DIABET M R, 15(3), 1999, pp. 181-185
Authors:
Dotta, F
Dionisi, S
Viglietta, V
Tiberti, C
Matteoli, MC
Cervoni, M
Bizzarri, C
Marietti, G
Testi, M
Multari, G
Lucentini, L
Di Mario, U
Citation: F. Dotta et al., T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitus, EUR J ENDOC, 141(3), 1999, pp. 272-278